These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17537250)

  • 1. Posttranslational N-glycosylation of the hepatitis B virus large envelope protein.
    Lambert C; Prange R
    Virol J; 2007 May; 4():45. PubMed ID: 17537250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
    Gallina A; Gazina E; Milanesi G
    Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
    Lu X; Mehta A; Dwek R; Butters T; Block T
    Virology; 1995 Nov; 213(2):660-5. PubMed ID: 7491790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chaperones involved in hepatitis B virus morphogenesis.
    Prange R; Werr M; Löffler-Mary H
    Biol Chem; 1999 Mar; 380(3):305-14. PubMed ID: 10223333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII.
    Bolt G; Kristensen C; Steenstrup TD
    Glycobiology; 2005 May; 15(5):541-7. PubMed ID: 15616124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian BiP controls posttranslational ER translocation of the hepatitis B virus large envelope protein.
    Awe K; Lambert C; Prange R
    FEBS Lett; 2008 Sep; 582(21-22):3179-84. PubMed ID: 18708056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-specific repression of cotranslational translocation of the hepatitis B virus envelope proteins coincides with binding of heat shock protein Hsc70.
    Löffler-Mary H; Werr M; Prange R
    Virology; 1997 Aug; 235(1):144-52. PubMed ID: 9300046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
    Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ
    Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
    Blanchet M; Sureau C
    J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular retention of duck hepatitis B virus large surface protein is independent of preS topology.
    Gazina EV; Lin B; Gallina A; Milanesi G; Anderson DA
    Virology; 1998 Mar; 242(2):266-78. PubMed ID: 9514970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
    Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
    Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity.
    Mårdberg K; Nyström K; Tarp MA; Trybala E; Clausen H; Bergström T; Olofsson S
    Glycobiology; 2004 Jul; 14(7):571-81. PubMed ID: 15044392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
    Mondotte JA; Lozach PY; Amara A; Gamarnik AV
    J Virol; 2007 Jul; 81(13):7136-48. PubMed ID: 17459925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of a 293 cell line with regulatable expression of the hepatitis B virus large envelope protein.
    Lambert C; Prange R
    J Virol Methods; 2004 Nov; 121(2):181-90. PubMed ID: 15381355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the minimal distance between the matrix and transmembrane domains of the large hepatitis B virus envelope protein.
    Kluge B; Schläger M; Pairan A; Bruss V
    J Virol; 2005 Jun; 79(12):7918-21. PubMed ID: 15919948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule.
    Wojczyk BS; Takahashi N; Levy MT; Andrews DW; Abrams WR; Wunner WH; Spitalnik SL
    Glycobiology; 2005 Jun; 15(6):655-66. PubMed ID: 15677380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.
    Patient R; Hourioux C; Vaudin P; Pagès JC; Roingeard P
    N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein.
    Hartmann-Stühler C; Prange R
    J Virol; 2001 Jun; 75(11):5343-51. PubMed ID: 11333915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis and function of prototype foamy virus envelope N glycosylation.
    Lüftenegger D; Picard-Maureau M; Stanke N; Rethwilm A; Lindemann D
    J Virol; 2005 Jun; 79(12):7664-72. PubMed ID: 15919919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.